Skip to main content
Donate

About FAST

Global Science Summit & Gala

5 photos of the summit and gala

Join Us at the Next One!

The next FAST Global Science Summit & Gala will be held November 5-7, 2026 in Orlando, FL

2025 Global Science Summit & Gala Recap

This is the biggest science and drug development event devoted to Angelman syndrome.

Learn more about the event.

International Guests

If you live outside of the United States and will need a visa to travel to the US, please consider applying now. If you would like FAST to write you a letter of invitation for you to enclose with your visa application, we are happy to do so. To request a letter of invitation, please email events@cureangelman.org and provide the full names of the people in your family who will attend.

Sponsors and Exhibitors

  • If your business or organization is interested in sponsoring or exhibiting at the event, please email events@cureangelman.org.

The Global Science Summit is preceded by the Translational Research Symposium and Angelman Syndrome Biomarker and Outcome Measure Consortium (A-BOM) meeting which will be on November 5, 2026 in Orlando, FL. This is an event for the research community by invite only. If you are interested in attending, email events@cureangelman.org.

TRS-ABOM

What is A-BOM?

Registration sign at TRS-ABOM in 2024.

FAST Angelman Syndrome News

Voice of the Patient Report Submitted: A Powerful Milestone for the Angelman Syndrome Community

FAST × ASA Angelman Syndrome Clinical Trials Webinar: Europe/UK Sites, Eligibility, and How to Join Trials

Remi Cup: Driving for a Cure to Angelman Syndrome

Rewind, Press Play, Kick AS: A Party With a Bigger Purpose

If Will CAN, We CAN: A Family’s Vision to #KickAS in Minneapolis

How Harper’s Hope Golf Tournament Has Raised Over $350,000 for Angelman Syndrome Research

MavriX Bio MVX-220 Update

Maddie's Mission Hits $1M Raised for Angelman Syndrome

Granville Angels Foundation: Bringing families together for Angelman syndrome

Reading the brain’s signals to speed better treatments for Angelman syndrome

Joe Bologna Charity Golf Outing Raises $36,000 for Sutton Strong and Angelman Syndrome Research

Ionis Receives Breakthrough Therapy Designation for ION582 in Angelman Syndrome

The Jack Pack’s 207 Miles of Hope

FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome

FAST Global: Cure Angelman Now Fundraising Efforts

CAN Spotlight: Payslie’s Pals Cornhole Tournament Brings Community Together for FAST Research

Turning Possibility Into Progress: The Rush F.A.S.T. Center for Translational Research Opens in Chicago

CAN Spotlight: Honoring “Hendu” with Hope and Research: The Always Having Fun Foundation’s Golf Classic

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelma...

The LaMuras organized Rally for a Cure, a Tennis-Themed Event that Brought Together Their Community

Voice of the Patient Report Submitted: A Powerful Milestone for the Angelman Syndrome Community

FAST × ASA Angelman Syndrome Clinical Trials Webinar: Europe/UK Sites, Eligibility, and How to Join Trials

Remi Cup: Driving for a Cure to Angelman Syndrome

Rewind, Press Play, Kick AS: A Party With a Bigger Purpose

If Will CAN, We CAN: A Family’s Vision to #KickAS in Minneapolis

How Harper’s Hope Golf Tournament Has Raised Over $350,000 for Angelman Syndrome Research

MavriX Bio MVX-220 Update

Maddie's Mission Hits $1M Raised for Angelman Syndrome

Granville Angels Foundation: Bringing families together for Angelman syndrome

Reading the brain’s signals to speed better treatments for Angelman syndrome

Joe Bologna Charity Golf Outing Raises $36,000 for Sutton Strong and Angelman Syndrome Research

Ionis Receives Breakthrough Therapy Designation for ION582 in Angelman Syndrome

The Jack Pack’s 207 Miles of Hope

FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome

FAST Global: Cure Angelman Now Fundraising Efforts

CAN Spotlight: Payslie’s Pals Cornhole Tournament Brings Community Together for FAST Research

Turning Possibility Into Progress: The Rush F.A.S.T. Center for Translational Research Opens in Chicago

CAN Spotlight: Honoring “Hendu” with Hope and Research: The Always Having Fun Foundation’s Golf Classic

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelma...

The LaMuras organized Rally for a Cure, a Tennis-Themed Event that Brought Together Their Community

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.